Verena Murphy

597 total citations
21 papers, 263 citations indexed

About

Verena Murphy is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Verena Murphy has authored 21 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Cancer Research and 4 papers in Genetics. Recurrent topics in Verena Murphy's work include Glioma Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Economic and Financial Impacts of Cancer (3 papers). Verena Murphy is often cited by papers focused on Glioma Diagnosis and Treatment (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Economic and Financial Impacts of Cancer (3 papers). Verena Murphy collaborates with scholars based in Ireland, United States and Netherlands. Verena Murphy's co-authors include Martin Clynes, Mary Heenan, Laura Breen, Paula Kinsella, William M. Gallagher, Jochen H.M. Prehn, Geoffrey J. Pilkington, Annette T. Byrne, Sharon Glaysher and Jeremy Hurren and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Verena Murphy

21 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Verena Murphy Ireland 8 129 71 69 56 27 21 263
Melanie Jackson United States 6 123 1.0× 77 1.1× 72 1.0× 91 1.6× 16 0.6× 11 372
Ling Gao China 10 160 1.2× 109 1.5× 74 1.1× 26 0.5× 40 1.5× 19 303
Christopher Farrell United States 8 131 1.0× 70 1.0× 70 1.0× 29 0.5× 39 1.4× 27 272
Cristina Corno Italy 13 301 2.3× 109 1.5× 55 0.8× 32 0.6× 38 1.4× 26 445
Rahel Fitzel Germany 4 141 1.1× 68 1.0× 66 1.0× 107 1.9× 39 1.4× 7 302
Kristell Oizel France 7 218 1.7× 52 0.7× 175 2.5× 77 1.4× 16 0.6× 7 345
Mauricio Rodriguez-Torres Canada 4 153 1.2× 183 2.6× 120 1.7× 29 0.5× 27 1.0× 4 311
Terreia S. Jones United States 11 163 1.3× 60 0.8× 54 0.8× 99 1.8× 22 0.8× 14 454
Jianwei Liao China 8 213 1.7× 98 1.4× 132 1.9× 15 0.3× 21 0.8× 12 314
Wanyin Chen China 10 277 2.1× 204 2.9× 125 1.8× 27 0.5× 36 1.3× 17 487

Countries citing papers authored by Verena Murphy

Since Specialization
Citations

This map shows the geographic impact of Verena Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Murphy more than expected).

Fields of papers citing papers by Verena Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Murphy. The network helps show where Verena Murphy may publish in the future.

Co-authorship network of co-authors of Verena Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Murphy. A scholar is included among the top collaborators of Verena Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Murphy. Verena Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gonzalez, Claudia Aura, Anthony O’Grady, Joanna Fay, et al.. (2023). The immune microenvironment in hormone positive, HER2 negative breast cancer: A focus on tumour infiltrating lymphocytes, spatial phenotypes and tertiary lymphoid structures.. Journal of Clinical Oncology. 41(16_suppl). 2522–2522. 1 indexed citations
2.
Harvey, Harry, Verena Murphy, Jo Ballot, et al.. (2023). The Impact of a National Cyberattack Affecting Clinical Trials: The Cancer Trials Ireland Experience. JCO Clinical Cancer Informatics. 4 indexed citations
3.
Harvey, Harry, et al.. (2022). Impact of Conti ransomware attack on cancer trials Ireland sites.. Journal of Clinical Oncology. 40(16_suppl). e13614–e13614. 1 indexed citations
4.
Gonzalez, Claudia Aura, Joanna Fay, Anthony O’Grady, et al.. (2022). CD45-positive tumor infiltrating lymphocytes in early-stage hormone-positive, HER2-negative (ER+/HER2-) breast cancer: Correlation with proliferation and prognostic signature scores.. Journal of Clinical Oncology. 40(16_suppl). e12555–e12555. 1 indexed citations
5.
O’Reilly, Séamus, Verena Murphy, Lisa Tucker, et al.. (2022). The SARS-CoV-2 Pandemic and Cancer Trials Ireland: Impact, Resolution and Legacy. Cancers. 14(9). 2247–2247. 7 indexed citations
6.
Kelly, Catherine M., John Crown, Stephen Barron, et al.. (2018). Comparison of the prognostic performance between OncoMasTR and OncotypeDX multigene signatures in hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.. Journal of Clinical Oncology. 36(15_suppl). 12074–12074. 1 indexed citations
7.
Kelly, Catherine M., John McCaffrey, Michelle L. Smith, et al.. (2017). Do oncology patients understand clinical trials? A nationwide study by Cancer Trials Ireland. Annals of Oncology. 28. v643–v644. 6 indexed citations
8.
Moran, Bruce, Sudipto Das, Dominiek Smeets, et al.. (2017). Assessment of concordance between fresh-frozen and formalin-fixed paraffin embedded tumor DNA methylation using a targeted sequencing approach. Oncotarget. 8(29). 48126–48137. 12 indexed citations
9.
10.
Grieken, Nicole C.T. van, Martijn Cordes, Henk M.W. Verheul, et al.. (2016). Copy number alterations as predictive biomarkers for response to bevacizumab in metastatic colorectal cancer. Annals of Oncology. 27. vi15–vi15. 1 indexed citations
11.
O’Connor, Miriam, Verena Murphy, Conleth G. Murphy, et al.. (2015). PO145 ICORG 13-01 ABC SURVEY: ARE WE MEETING THE NEEDS OF PATIENTS WITH ADVANCED BREAST CANCER (ABC) IN IRELAND? A NATIONWIDE SURVEY. The Breast. 24. S71–S72. 1 indexed citations
12.
Jarzabek, Monika A., Verena Murphy, John J. Callanan, et al.. (2014). Interrogation of gossypol therapy in glioblastoma implementing cell line and patient-derived tumour models. British Journal of Cancer. 111(12). 2275–2286. 24 indexed citations
13.
Murphy, Verena, et al.. (2013). Are Systems‐Centered® teams more collaborative, productive and creative?. Team Performance Management. 19(3/4). 201–221. 4 indexed citations
14.
Kinsella, Paula, Padraig Doolan, Colin Clarke, et al.. (2012). Characterization and response of newly developed high-grade glioma cultures to the tyrosine kinase inhibitors, erlotinib, gefitinib and imatinib. Experimental Cell Research. 318(5). 641–652. 10 indexed citations
15.
Kinsella, Paula, Patrick G. Buckley, Leah Alcock, et al.. (2012). Comparative genomic and proteomic analysis of high grade glioma primary cultures and matched tumor in situ. Experimental Cell Research. 318(17). 2245–2256. 5 indexed citations
16.
Glaysher, Sharon, Jeremy Hurren, Louise A. Knight, et al.. (2011). The effect of tricyclic antidepressants on cutaneous melanoma cell lines and primary cell cultures. Anti-Cancer Drugs. 23(1). 65–69. 24 indexed citations
17.
Kinsella, Paula, Martin Clynes, & Verena Murphy. (2010). Imatinib and docetaxel in combination can effectively inhibit glioma invasion in an in vitro 3D invasion assay. Journal of Neuro-Oncology. 101(2). 189–198. 17 indexed citations
18.
Bilimoria, Diana, Deborah A. O’Neil, Margaret M. Hopkins, & Verena Murphy. (2010). Gender in the Management Education Classroom: A Collaborative Learning Journey. Organizational Behavior Teaching Review. 34(6). 848–873. 8 indexed citations
19.
Murphy, Verena. (2009). Hypoxia Helps Glioma to Fight Therapy. Current Cancer Drug Targets. 9(3). 381–390. 88 indexed citations
20.
Breen, Laura, Mary Heenan, Verena Murphy, & Martin Clynes. (2007). Investigation of the role of p53 in chemotherapy resistance of lung cancer cell lines.. PubMed. 27(3A). 1361–4. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melanie Jackson Breakdown of academic impact, for papers by Ling Gao Breakdown of academic impact, for papers by Christopher Farrell Breakdown of academic impact, for papers by Cristina Corno Breakdown of academic impact, for papers by Rahel Fitzel Breakdown of academic impact, for papers by Kristell Oizel Breakdown of academic impact, for papers by Mauricio Rodriguez-Torres Breakdown of academic impact, for papers by Terreia S. Jones Breakdown of academic impact, for papers by Jianwei Liao Breakdown of academic impact, for papers by Wanyin Chen
Rankless by CCL
2026